Private Equity

The State of the Ophthalmology Sector Five Years into Private Equity Investment – On Thursday June 27, Provident and Edelstein are co-hosting a webinar which will educate ophthalmologists and executives on the current transaction environment within the ophthalmology sector, providing shareholders insight on the varying transaction options and structures afforded in today’s environment, in addition to guidance on how to prepare for a transaction process.

Health-Care Deals Steady, Strong Through First Third of 2019– Consistency is the name of the game for health-care industry transactions in 2019 so far.

INSIGHT: Health Care M&A Transactions on Pace to Set Record in 2019– March madness is over for college basketball fans, but it’s just the beginning of a fast-paced year for health-care M&A activity.

Baby Steps – Ob Hospitalist Group is working to improve women’s health care, one hospital at a time AJ Shekar provides some insight on PE investment in hospital outsourcing businesses

HI2 Conference – Steven Aguiar will be attending the conference, taking place June 17-19 in Chicago.

Investment in IPM: Challenges and Opportunities – On Wednesday May 22, Provident and Husch Blackwell co-hosted a webinar which focused on providing pain management providers and operators with an industry update regarding the current trends and transaction activity driving today’s pain market, how to evaluate the best long-term partner, and the potential risks associated with pursuing a transaction. The recording for this webinar is now available.

The PE time bomb — Provident’s Abe M’Bodj on where investment in GI is headed in 2019 – Abe M’Bodj analyzes the current state of the GI market and offers insights into what the rest of the year could look like as well as how all PE firms can coexist.

Q1-2019 Private Equity Industry Update– Volatile public markets and political uncertainty are likely the cause of lower activity in Q1 2019 for both deal volume and capital invested. Due to the lack of investments, this is likely to leave a substantial amount of dry powder that can stimulate consolidation towards the end of the year.

BioScrip, Option Care Will Join Forces Within Infusion Market – Micheal Patton and Bill Bolding share some of their insight on the specialty pharmacy space with Radar on Specialty Pharmacy.

Current State of the DSO Market On Thursday April 25, Provident and Pepper Hamilton co-hosted a webinar which focused on private equity-led investment and consolidation activity within the dental sector. The recording for the webinar is now available.

Long-Term Care Deals Dominate Health Industry in February– The long-term care sector continued its domination of health-care deals in February, Bloomberg Law’s transactions advisory board says.

‘Add-on Acquisition’ Deals in 2018 Were Key to PE Growth in Ophthalmology Sector, Report Finds – Consolidation activity within the ophthalmology sector remained very active through the fourth quarter of 2018, a year in which there were at least 10 transactions publicly disclosed in every quarter

Private Equity Interest in Hospice Acquisition Expected to Rise in 2019 – As more private equity firms enter the post-acute health care arena, hospice organizations are increasingly pursuing mergers and acquisitions as a growth strategy, according to the recently released 4th quarter 2018 Home Health & Hospice Update from Provident Healthcare Partners.

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”